MedCity News October 25, 2022
Robin Farmanfarmaian

Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company’s medication by their physician.

The U.S. healthcare industry has adopted the basic phone call, video call, and email with a healthcare professional as telemedicine. But telemedicine extends significantly farther than the synchronous healthcare delivery of a phone call or video session. Any type of software, connected device, or treatment prescribed and monitored by a healthcare professional and accessed by patients in their daily lives can be considered telemedicine, sometimes referred to as asynchronous telemedicine or virtual care.

Clinical trials are typically the only time a pharmaceutical company has direct insight into the individuals who use their medication. Once a medication is...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Technology, Telehealth
MHE Week in Review – New PBM Reform Bill, Cardiac Diseases Cost
Deep learning uncovers gene targets and potential drugs to slow brain aging
FDA issues flu vaccine recommendations: 5 respiratory updates
CZI’s Priscilla Chan on ‘Virtual Cells’ AI Models to Cure Diseases
HIMSSCast: The 'genetic revolution' is underway

Share This Article